Transgene Biotek Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
Transgene Biotek Ltd · Financial Result · 13 Nov 2026, 6:53 pm
Transgene Biotek Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 6.0 (+13.6% YoY | +0.0% QoQ) ■ EBITDA: -1.5 (+80.5% YoY | +75.1% QoQ) ■ EBITDA Margin (%): -24.2 (+11655 bps YoY | +7283 bps QoQ) ■ PAT: -34.5 (+11.1% YoY | +11.2% QoQ) ■ EPS (INR): -0.05 (+0.0% YoY | +0.0% QoQ)
Original exchange filing (PDF)
More announcements from Transgene Biotek Ltd
- CUT OFF DATE · 13 Nov 2026
- 1) Unaudited Financial Results: Considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended 30th September, .... · 13 Nov 2026
- Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve To consider and approve the .... · 13 Nov 2026
- 1. RESIGNATION OF M/S. HARISH GUMMADI & CO., CHARTERED ACCOUNTANTS: The Board took note of the resignation letter dated 03rd November, 2026, submitted by M/s. Harish Gummadi & Co., Chartered .... · 04 Nov 2026
- Intimation of Resignation of Statutory of Auditors - M/S. Harish Gummadi & Co.., Chartered Accountants. · 04 Nov 2026
- 1. APPOINTMENT OF STATUTORY AUDITORS TO FILL THE CASUAL VACANCY: The Board of Directors, based on the recommendation of the Audit Committee, has approved the appointment of M/s. Harish .... · 02 Nov 2026
- Submission of Additional Details Pursuant to BSE Observation -Resignation of Statutory Auditors under Regulation 30 of SEBI (LODR) Regulations, 2015. · 01 Nov 2026
- Submission of Additional Details pursuant to BSE Observation -Resignation of Statutory Auditors under Regulation 30 of SEBI (LODR) Regulation, 2015. · 01 Nov 2026
